Short term and long term health related quality of life after congenital anorectal malformations and congenital diaphragmatic hernia by Poley, M.J. (Marten) et al.
doi:10.1136/adc.2002.016543 
 2004;89;836-841 Arch. Dis. Child.
  
M J Poley, E A Stolk, D Tibboel, J C Molenaar and J J V Busschbach 
  
 congenital diaphragmatic hernia
life after congenital anorectal malformations and 
Short term and long term health related quality of
 http://adc.bmjjournals.com/cgi/content/full/89/9/836




 "Web-only Tables and Figures"
 References
 http://adc.bmjjournals.com/cgi/content/full/89/9/836#otherarticles
1 online articles that cite this article can be accessed at: 
  
 http://adc.bmjjournals.com/cgi/content/full/89/9/836#BIBL
This article cites 32 articles, 6 of which can be accessed free at: 
Rapid responses
 http://adc.bmjjournals.com/cgi/eletter-submit/89/9/836
You can respond to this article at: 
 service
Email alerting
top right corner of the article 
Receive free email alerts when new articles cite this article - sign up in the box at the
Topic collections
 (1775 articles) Children 
 (251 articles) Gastrointestinal Surgery 
 (761 articles) Other Gastroenterology 
  
Articles on similar topics can be found in the following collections 
 Notes   
 http://www.bmjjournals.com/cgi/reprintform
To order reprints of this article go to: 
 http://www.bmjjournals.com/subscriptions/
 go to: Archives of Disease in ChildhoodTo subscribe to 
 on 1 November 2006 adc.bmjjournals.comDownloaded from 
ORIGINAL ARTICLE
Short term and long term health related quality of life after
congenital anorectal malformations and congenital
diaphragmatic hernia
M J Poley, E A Stolk, D Tibboel, J C Molenaar, J J V Busschbach
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Tables A and B and
Figures A and B are




See end of article for
authors’ affiliations
. . . . . . . . . . . . . . . . . . . . . . .
Correspondence to:









. . . . . . . . . . . . . . . . . . . . . . .
Arch Dis Child 2004;89:836–841. doi: 10.1136/adc.2002.016543
Aims: To examine short term and long term health related quality of life (HRQoL) of survivors of congenital
anorectal malformations (ARM) and congenital diaphragmatic hernia (CDH), and to compare these
patients’ HRQoL with that of the general population.
Methods: HRQoL was measured in 286 ARM patients and 111 CDH patients. All patients were
administered a symptom checklist and a generic HRQoL measure. For the youngest children (aged 1–4)
the TAIQOL (a preliminary version of the TAPQOL) was used, for the other children (aged 5–15) the
TACQOL questionnaire, and for adults (aged .16) the SF-36.
Results: As appeared from the symptom checklists, many patients remained symptomatic into adulthood.
In the youngest ARM patients (aged 1–4 years), generic HRQoL was severely affected, but the older ARM
patients showed better HRQoL. In the CDH patients, the influence of symptoms on HRQoL seemed less
profound. The instruments we used revealed little difference between adults treated for ARM or CDH and
the general population.
Conclusions: These results show that for two neonatal surgical procedures, improved survival does not
come at the expense of poor HRQoL in adults. Even though there is considerable suffering in terms of both
morbidity and mortality in the youngest group, the ultimate prognosis of survivors of the two studied
congenital malformations is favourable. This finding can be used to reassure parents of patients in need of
neonatal surgery for one of these conditions about the prospects for their child.
I
mproved survival among neonates with previously life
threatening congenital anomalies has created new dilem-
mas in neonatal surgery. Mere survival is no longer
sufficient; the child’s future health related quality of life
(HRQoL) is equally important. Moreover, the large amount of
economic resources currently spent on neonatal care, coupled
with increasing budget constraints, has evoked the question
of whether the effects of a given treatment are worth the
costs.1–3 There is growing political interest in evidence based,
cost effective medicine, including paediatric surgery.
Recently, we reviewed the literature dated 1989–98 on the
prognosis in terms of HRQoL of newborns operated on for the
congenital anomalies listed by Ravitch and colleagues.1 4 It
appeared that many studies fail to establish HRQoL and only
present mortality rates and crude measures of childhood
morbidity. With few exceptions,5 6 follow up data in adults
are lacking. Furthermore, most studies appeared to stress
physical rather than social or psychological functioning. To
estimate the significance to an individual of an impairment
or a functional limitation, generic HRQoL measures—
containing physical, mental, and social domains—should be
used. These allow for comparisons across patients suffering
from various conditions, bringing out the relative severity of
diseases.
To fill the knowledge gap, we analysed long term HRQoL
effects for congenital anorectal malformations (ARM) and
congenital diaphragmatic hernia (CDH). Studies in ARM
patients, which predominantly focused on impairments and
limitations in specific domains of functioning, suggested
a relatively poor long term HRQoL, even after successful
surgical reconstruction.7–9 CDH patients, though often faced
with life threatening morbidity during the neonatal period
and a variety of symptoms in their first years of life,10–12
generally seem to lead healthy lives eventually. This study
attempts to clarify the HRQoL of survivors of ARM and CDH
in a lifetime setting and looks to the question of how it
compares with that of the general population.
METHODS
Patients
The patient population was comprised of patients treated for
ARM or CDH after the year 1969 in the Sophia Children’s
Hospital, a level III children’s hospital serving a referral area
of 3.5 million inhabitants. Patients born after the year 1996
were excluded to ensure a minimal period of one year
between the patient’s birth and the date of investigation.
Data were collected from 1997 to 1999. Study questionnaires
were distributed by post. If patients did not respond, they
were reminded once with a telephone call.
Outcome measures
The patients or their parents were asked to complete both a
symptom checklist created by ourselves and an existing
generic HRQoL questionnaire. The former served to measure
symptoms. A symptom is defined as a patient’s perception of
an abnormal physical, emotional, or cognitive state.13 Patients
Abbreviations: ARM, congenital anorectal malformations; CDH,
congenital diaphragmatic hernia; ECMO, extracorporeal membrane
oxygenation; HRQoL, health related quality of life
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aged from 12 years filled in the symptom checklist
themselves. Parents filled in proxy versions of the ques-
tionnaires on behalf of younger patients.
Because of the rapid developmental change in children,
different HRQoL questionnaires had to be used for three age
groups. These were the TNO-AZL Infant Quality of Life
(TAIQOL) questionnaire (ages 1–4), the TNO-AZL Children’s
Quality of Life (TACQOL) questionnaire (ages 5–15), and the
MOS Short-Form 36 (SF-36) questionnaire (ages 16+). The
HRQoL questionnaires were self administered from 16 years
on.
Symptom checklists
The symptom checklist for ARM patients was comprised of
seven items, among which were lack of urge sensation,
inability to hold faeces, the use of aids for defecation and
diapers, and urinary incontinence (see table A, available on
the ADC website). The total symptom score ranges from 0 to
12, representing maximum symptomatology. The CDH
symptom checklist, covering 14 items, dealt with several
respiratory difficulties and stomach problems (see table B,
available on the ADC website). Again, higher scores corre-
spond to more severe symptomatology, with a maximum
score of 45.
Clearly, the symptoms studied may also be prevalent in the
general population. For example, lack of continence occurs in
children born with ARM as well as in healthy children up to a
certain age. Therefore, we set out to determine reference
scores using a randomly selected sample of children who
visited the day-care department of our hospital in 1998 for
minor day-case surgery. These controls, who had no record of
stool difficulties or respiratory problems, were administered
both the ARM checklist and the CDH checklist.
TAIQOL questionnaire
The TAIQOL questionnaire was developed to be a reliable and
valid instrument for measuring HRQoL in children between
the ages of 1 and 4.14 It includes 13 domains: lungs, stomach,
skin, sleeping, appetite, eating problems, aggressive beha-
viour, positive emotions, emotions of anxiety, vitality, social
behaviour, motor problems, and communication. The last
three domains are applicable only to children aged 18 months
and older. The number of items per domain varies from three
to seven. Regarding eight of the domains, the TAIQOL
investigates HRQoL by assessing functional problems
weighted by the degree to which a child shows negative
emotions in response to such problems. An example of such a
TAIQOL item pair is presented in fig A (see the ADC website).
In the other five domains, the TAIQOL only measures the
frequency of a specific limitation (see fig B on the ADC
website for an example). Crude domain scores were linearly
transformed to a 0–100 scale, with higher scores indicating
better HRQoL.
TACQOL questionnaire
The developers of the TAIQOL also created an instrument for
use with children between the ages of 5 and 15 years, named
the TACQOL questionnaire.15 Its seven domains are: pain and
symptoms, basic motor functioning, autonomy, cognitive
functioning, social functioning, global positive emotional
functioning, and global negative emotional functioning. Each
domain consists of eight item pairs.16 The first part of each
item assesses the presence of health status problems. The
second part assesses the emotional response to such pro-
blems. As with the TAIQOL questionnaire, each item pair is
encoded into one single score, ranging from 0 to 4. However,
no emotional responses are asked regarding ‘‘global positive
emotional functioning’’ and ‘‘global negative emotional
functioning’’, since this would lead to nonsensical results.
In these two domains, the item scores range from
0 to 2. Consequently, the domain scores range from 0 to 32
for all domains, except those concerning emotional function-
ing, which range from 0 to 16. Higher scores correspond to
better HRQoL. Both the TAIQOL and the TACQOL have been
validated in several patient groups since they came into use,
with promising results.16 17
SF-36 questionnaire
The SF-36 questionnaire consists of 36 items organised into
eight domains: physical functioning, role–physical, bodily
pain, general health, vitality, social functioning, role–
emotional, and mental health. The SF-36 domain scores
range from 0 to 100, with higher scores indicating better
HRQoL. Results can be aggregated into a physical and a
mental health summary measure. These summary measures
were linearly transformed to a mean of 50 and standard
deviations of 10 in the general US population. Evidence on
the psychometric performance of the widely used SF-36 is
mounting.18 19
Statistics
Statistical analyses were carried out using the t test for two
independent sample means and the t test for the significance
of a correlation (two-tail probabilities). Results were con-




Of all 526 ARM patients and 285 CDH patients who
underwent treatment for their conditions in the study period,
we excluded patients who were deceased (ARM, n=54;
CDH, n=86), were severely cognitively disabled (ARM,
n=8; CDH, n=7), or could not be traced (ARM, n=53;
CDH, n=24). The remaining 411 ARM patients and 168 CDH
patients were sent questionnaires. The response rate
amounted to 70% (n=286) in ARM patients and 66%
(n=111) in CDH patients. Because extracorporeal mem-
brane oxygenation (ECMO) was not applied in the hospital
until January 1992, only four (all in the 1–4 years age group)
of all 111 CDH patients participating in this study were
treated with ECMO.
The respondents did not differ from the non-respondents
in terms of sex or age. Males comprised a larger proportion of
the respondents (59% in ARM patients versus 53% in CDH
patients). ARM patients were between 1 and 51 years of age
(mean 15.1, SD 9.4). Age ranged from 1 to 42 years in CDH
patients (mean 14.3, SD 8.6). There were no differences
between ARM and CDH patients and the general population
with respect to educational level, involvement in a relation-
ship, or having children.
Symptom checklists were sent to (the caregivers of) 72
children in the control group and returned by 53 (74%).
Disease specific symptoms
Across all age groups, ARM patients had higher symptom
scores than the control group (table 1). Over the years, the
symptom score decreased in ARM patients, but remained
statistically significantly higher than that of the reference
group. To mention a few examples: 68% of all ARM patients
sometimes or regularly soiled themselves versus 32% in the
control group. Compared to the reference group, a relatively
small part of the ARM patients was able to hold faeces for at
least one minute (67% v 92%) or was able to recognise the
type of faeces (64% v 85%).
The results presented in table 1 provide fairly strong
evidence that, overall, the symptom score in CDH patients
was higher than that of the control population. In the control
Short term and long term quality of life after ARM and CDH 837
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group, the symptom score showed a clear decrease over the
years, which does not match the pattern found in the CDH
patients. Many respiratory difficulties and stomach problems
were not unique to CDH patients, but almost all symptoms
were reported more frequently in CDH patients than in the
control group. For example, 76% of all CDH patients never
coughed up sputum when waking up, in comparison with
90% in the control group. Of the CDH patients, 77% never
experienced constraints as a result of respiratory difficulties,
compared to 91% in the control group.
Health related quality of life
In the youngest age group, differences in HRQoL between
patients and the general population were found (table 2). In
as many as eight of the 13 TAIQOL domains, the difference
between ARM patients and the general population is
considered statistically significant. Of note is the low score
of the ARM patients on the stomach domain, which consists
of the items stomach ache or abdominal pain, colic, and
nausea. In most domains, the scores of the CDH patients
exceeded those found in the ARM patients. Nevertheless,
statistically significant differences between the CDH sample
and the reference group were found in five domains. By
conventional statistical criteria, we found no clear evidence of
a difference in the domain ‘‘lungs’’, which is composed of the
items bronchitis, difficulties with breathing or lung problems,
and shortness of breath.
Tables 3 and 4 present the results of the TACQOL and the
SF-36. In ARM patients, four TACQOL domains appeared to
discriminate between patients and the general population.
The outcomes indicate that the CDH patients scored relatively
low in the domains ‘‘basic motor functioning’’ and ‘‘cognitive
functioning’’. Neither in ARM patients nor in CDH patients
did the eight domains of the SF-36 or the physical summary
measure discriminate between patients and the general
population (table 4). The mental summary measure suggests
that ARM and CDH patients are even healthier than the
general population. In summary, the long term outlook of
survivors of these congenital anomalies is favourable. How-
ever, there appeared to be some variability in the data,
implying that small subgroups of the patients scored rela-
tively low on the HRQoL questionnaires. The poor HRQoL
outcomes in these subgroups were associated with the
presence of disease specific symptoms. This is illustrated by
the negative relation between the SF-36 physical summary
score and the symptom score (Pearson’s correlation 20.41 in
ARM patients (n=124; p , 0.001) v 20.50 in CDH patients
(n=50; p , 0.001)). The correlation between the SF-36
Table 1 Symptom scores of ARM patients and CDH patients compared with reference scores
Age class
ARM patients CDH patients Reference group




(SD) n Mean age
Mean score
(SD) n Mean age ARM CDH
1–4 y 40 2.7 5.9 (3.3) 20 2.9 7.3 (6.1) 18 3.0 3.5 (1.7 to 5.3)*** 1.6 (22.6 to 5.8)
5–10 y 67 7.2 4.2 (3.1) 23 8.0 7.5 (7.4) 22 7.3 2.9 (1.5 to 4.3)*** 2.4 (21.4 to 6.2)
11–15 y 52 12.9 3.8 (2.9) 16 13.5 5.9 (5.1) 11 12.9 3.2 (1.4 to 5.0)*** 2.1 (21.4 to 5.6)
>16 y 127 23.8 2.7 (2.5) 52 21.8 7.1 (5.4) 2 17.0 2.7` 4.3`
Total 286 15.0 3.7 (3.0) 111 14.3 7.0 (5.9) 53 7.4 2.2 (1.4 to 3.1)*** 2.1 (0.2 to 3.9)*
A missing value analysis (using an expectation-maximisation algorithm) was performed for 79 (16%) of all 503 calculated symptom scores.
95% confidence interval for the difference between the group means.
`Difference not tested (because of small sample size).
*Significant at p , 0.05.
***Significant at p , 0.001.
Table 2 TAIQOL scores of ARM patients and CDH patients aged 1–4 years compared with reference scores
Domain
Mean scores (SD) Difference with ref. group (95% CI`)
ARM (n = 411) CDH (n = 20) ARM CDH
Lungs 91.3 (21.0) 86.8 (18.7) 22.2 (27.7 to 3.4) 26.6 (214.1 to 0.9)
Stomach 65.4 (23.8) 84.2 (22.6) 226.5 (231.6 to 221.5)*** 27.8 (214.4 to 21.1)*
Skin 91.1 (11.2) 94.2 (9.8) 20.9 (24.4 to 2.6) 2.2 (22.5 to 7.0)
Sleeping 73.0 (22.5) 81.6 (24.6) 29.0 (214.9 to 23.1)** 20.5 (28.6 to 7.6)
Appetite 76.9 (16.7) 87.7 (10.9) 27.5 (212.0 to 23.1)** 3.3 (22.7 to 9.3)
Eating problems 83.1 (15.8) 91.7 (11.8) 213.0 (216.0 to 210.0)*** 24.5 (28.2 to 20.7)*
Aggressive behaviour 64.1 (18.2) 66.8 (19.1) 23.6 (28.7 to 1.6) 20.9 (28.0 to 6.2)
Positive emotions 93.5 (17.0) 94.7 (13.7) 25.2 (27.9 to 22.4)*** 23.9 (27.2 to 20.6)*
Emotions of anxiety 66.7 (21.1) 76.7 (17.4) 211.4 (217.4 to 25.4)*** 21.4 (29.5 to 6.8)
Vitality 88.2 (23.0) 92.5 (19.1) 29.8 (213.3 to 26.2)*** 25.5 (29.6 to 21.3)**
For children from 18 months of age
Social behaviour 88.0 (19.8) 87.5 (19.4) 23.0 (29.5 to 3.5) 23.5 (212.3 to 5.3)
Motor problems 92.9 (12.5) 88.4 (10.4) 25.8 (27.6 to 23.9)*** 210.3 (212.3 to 28.2)***
Communication 88.6 (14.5) 89.8 (13.0) 23.0 (26.5 to 0.5) 21.8 (26.4 to 2.8)
Reference scores (n = 323) were obtained from the creators of the instrument at TNO Prevention and Health, Netherlands (unpublished data). After our
investigation, the TAIQOL was replaced by the almost identical TNO-AZL Preschool Children Quality of Life (TAPQOL) questionnaire. Normative data of the
TAPQOL, of which an English version is available, have been published.17
`95% confidence interval for the difference between the group means.
1n = 39 for the domains only applicable to children from 18 months of age.
*Significant at p , 0.05.
**Significant at p , 0.01.
***Significant at p , 0.001.
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mental summary score and the symptom score amounted to
20.20 in ARM patients (n=124; p=0.02) and20.47 in CDH
patients (n=50; p=0.001).
DISCUSSION
In this paper, we have been concerned with the HRQoL of
survivors of ARM and CDH in a long term setting. Many
of them appeared to retain substantial residual sympto-
matology. Compared with reference data, the HRQoL of the
patients (especially those with ARM) aged 1–4 was poor. In
the patients aged 16 years and over, hardly any differences
with the general population were found. It must be
stressed that the relatively poor outcomes in the youngest
patients are not offset by the encouraging outcomes in
adult life. This stage of life has its own inherent impor-
tance for the developing individual. Therefore, future
research should especially be targeted at finding ways to
improve the HRQoL of the youngest children. It is clear from
the current study that the relations between symptoms,
impairments, limitations in functioning, and HRQoL should
be interpreted with caution. An important lesson to be
learned is that impairments are imperfect predictors of
HRQoL. Not every impairment automatically triggers a
decrease of the HRQoL.
The HRQoL of the ARM patients aged between 1 and 4
years was statistically significantly lower than population
standards predicted, even though complaints of incontinence
are not prominent until patients grow older. Their HRQoL
improved considerably with growing age, notwithstanding
the fact that stool difficulties are widely believed to
disrupt HRQoL due to pain, feelings of shame, or inability
to take part in social activities such as sports. A possible
explanation is that diapers, therapeutic aids such as
enemas, and dietary manipulations are effective tools in
restoring satisfying functioning. Seemingly, the patients are
able to cope successfully with their handicaps in one way
or another.
A HRQoL questionnaire did not reveal a pronounced
difference in the lung domain between CDH patients aged
1–4 years and a reference group. In a sense, these results are
consistent with earlier research we performed in this specific
patient group (median age 11.7 years) using lung function
tests.12 This study showed that in the long term no severe
pulmonary impairment resulted from CDH. The reduced
level of cognitive functioning in the CDH patients aged 5–15
years (none treated with ECMO) corroborates a small scale
study previously carried out in our hospital.20 In the current
study, from a certain age the HRQoL of the CDH patients
could hardly be distinguished from that of the general
population. One explanation is that, particularly in the past, a
major ‘‘selection’’ took place in the first week of life due to
the high mortality in patients with severe pulmonary
hypoplasia and therapy resistant pulmonary hypertension.
In other words, those patients in the worst shape are likely
not to have survived. Finally, it should be noted that,
while ECMO improves survival in selected, critically ill
infants with CDH,21 it is also true that the ECMO technique
enables us to keep some patients alive with a relatively poor
Table 3 TACQOL scores of ARM patients and CDH patients aged 5–15 years compared with reference scores
Domain
Mean scores (SD) Difference with ref. group (95% CI`)
ARM (n = 118) CDH (n = 39) ARM CDH
Pain and symptoms 27.5 (3.5) 28.1 (2.9) 20.1 (20.8 to 0.6) 0.5 (20.6 to 1.7)
Basic motor functioning 30.0 (4.0) 30.3 (3.0) 21.0 (21.5 to 20.6)*** 20.7 (21.5 to 0.0)*
Autonomy 30.6 (3.2) 30.9 (2.5) 20.8 (21.1 to 20.4)*** 20.4 (21.0 to 0.2)
Cognitive functioning 29.0 (4.8) 28.3 (4.2) 20.5 (21.2 to 0.2) 21.2 (22.4 to 20.1)*
Social functioning 29.3 (3.7) 29.9 (2.3) 20.7 (21.2 to 20.3)** 20.1 (20.8 to 0.6)
Global positive emotional functioning 14.6 (2.3) 14.8 (1.8) 20.4 (20.7 to 0.0)* 20.2 (20.8 to 0.4)
Global negative emotional functioning 11.9 (2.5) 12.4 (2.3) 0.2 (20.3 to 0.6) 0.7 (0.0 to 1.5)
The English version of the TACQOL is available on request.
Reference scores (n = 1311) were derived from a random sample of Dutch children (aged 6–11) in the general population after exclusion of all children with any
(parent reported) chronic condition.16 The means and standard deviations of six age and sex matched groups were combined.
`95% confidence interval for the difference between the group means.
*Significant at p , 0.05.
**Significant at p , 0.01.
***Significant at p , 0.001.
Table 4 SF-36 scores of ARM patients and CDH patients aged 16 years and older compared with reference scores
Domain
Mean scores (SD) Difference with ref. group (95% CI`)
ARM (n = 127) CDH (n = 52) ARM CDH
Physical functioning 92.8 (14.3) 93.7 (14.0) 20.3 (22.7 to 2.1) 0.6 (22.8 to 4.0)
Role–physical 87.6 (28.5) 90.2 (28.8) 1.2 (24.2 to 6.6) 3.8 (24.1 to 11.7)
Bodily pain 78.2 (17.0) 83.5 (11.4) 22.7 (26.3 to 1.0) 2.6 (22.8 to 8.0)
General health 75.3 (22.1) 78.5 (17.7) 22.9 (26.4 to 0.7) 0.3 (24.7 to 5.2)
Vitality 68.0 (17.2) 68.1 (21.7) 22.7 (25.9 to 0.5) 22.6 (27.4 to 2.2)
Social functioning 89.9 (15.6) 91.1 (20.3) 2.1 (21.5 to 5.6) 3.3 (22.2 to 8.8)
Role–emotional 90.1 (26.8) 90.9 (28.3) 4.7 (21.0 to 10.4) 5.4 (23.1 to 14.0)
Mental health 78.3 (15.1) 77.4 (19.4) 20.4 (23.4 to 2.5) 21.3 (25.8 to 3.1)
Physical component summary 52.2 (7.7) 53.7 (5.2) 20.7 (22.1 to 0.7) 0.9 (21.2 to 3.0)
Mental component summary 52.5 (8.0) 51.9 (10.9) 3.6 (1.8 to 5.3)*** 3.0 (0.3 to 5.7)*
Details of the SF-36 are available at http://www.sf-36.org/demos/SF-36.html.
Reference scores for the eight ‘‘individual’’ domains were derived from a Dutch general population sample, aged 16–40. ‘‘n’’ was estimated at 551 on the basis
of the fact that the total sample, aged 16–94, contained 1742 people.34 To obtain reference scores for the summary scales, we had to rely on a US general
population sample, aged 18–44 (n = 2765).35
`95% confidence interval for the difference between the group means.
*Significant at p , 0.05.
***Significant at p , 0.001.
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prognosis and that it may lead to iatrogenic morbidity.22
Thus, close follow up of CDH patients becomes even more
essential in the future.
When evaluating the outcome of ARM and CDH, we did
not include the patients who had died. Although it is of major
importance to critically evaluate the deaths—as was done
earlier in our paediatric surgical department23 24—this was
beyond the scope of the current study. Here, we concentrated
on assessing whether improved survival in neonatal surgery
comes at the expense of poor HRQoL. Apart from that, 78% of
the 54 deceased ARM patients died within their first year of
life, with a median life span of 23 days. Of the 86 CDH
patients who died, 87% died within their first year of life
(median life span 3 days). The vast majority of the deceased
were therefore too young to assess the quality of their lives.
Similarly, we did not assess patients who were severely
cognitively disabled. Cognitive disability, which is attributa-
ble to a wide variety of underlying causes ranging from
birth asphyxia to severe chromosomal anomalies (including
trisomy 21), is not common in these patient groups. Only
1.8% of all eligible patients had to be excluded for this
reason (n=15; mean age 24.6 years). A solid investigation
into the HRQoL of this subgroup would have been difficult
to accomplish within the current study. HRQoL can be
assessed by proxy in these subjects, but one must seriously
doubt whether the measures used would be sufficiently
valid and reliable in these cases. The severely cognitively
disabled patients may differ in their perception of HRQoL,
and their ability to express their experiences is often very
limited. This may reduce the parents’ or caregivers’ ability to
make accurate judgements about aspects of the patient’s
HRQoL.
Assessment of HRQoL in children poses special problems.
Because of difficulties that small children have with notions
of abstract concepts and language, we had to rely on proxies.
We are conscious of the variety of factors that can influence a
parent’s rating of his or her child’s HRQoL and the equivocal
findings reported in the literature.25–27 Nevertheless, recent
research findings in children28–30 suggest that a parent is able
to report appropriate information regarding his or her child’s
HRQoL, especially concerning observable behaviours. There is
as yet no clear evidence of whether—when the parent and
the child disagree—the parents over- or under-estimate
HRQoL. A number of studies indicated that parents tend to
rate the child as having a poorer HRQoL than the child does
him or herself, a tendency which would result in a
conservative estimate of the HRQoL.31–33 These studies, often
concentrating on acquired conditions, apply, however to
children aged between about 7 and 13, who are able to give
self reports, while our study also comprised younger children.
Finally, as in most previous studies in this area, we limited
ourselves to one source of information and did not obtain
additional views of, for example, other relatives or teachers.
Yet, the use of proxies other than parents may have value and
merits further investigation.
In conclusion, our investigation into the HRQoL of
survivors of ARM and CDH provides favourable results. The
suggestion that improved survival can only be reached at the
price of poor HRQoL is not substantiated. As expected a
priori, ARM and CDH can cause considerable symptomatol-
ogy. Nevertheless, the vast majority of the patients ultimately
enjoy healthy lives.
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Pathologists’ terminology for sudden infant deaths
W
hatever terms are used for sudden unexpected deaths in infancy (SUDI) it is
important that terminology should be agreed and standardised; everybody should
‘‘sing from the same hymn sheet’’. A survey carried out for the Foundation for the
study of Infant Deaths, in collaboration with the Office of National Statistics and the Royal
College of Pathologists (S Limerick and C Bacon. J Clin Pathol 2004;57:309–11) has shown
that pathologists vary in their use of terms when reporting on SUDI.
A questionnaire was sent to all 105 pathologists known by the Royal College of
Pathologists to perform SUDI autopsies. There were 63 satisfactory replies (five responders
said they no longer did SUDI autopsies and there were 37 nonresponders). Of the 63, 29
were forensic pathologists, 24 paediatric pathologists, and 10 general pathologists (six with
forensic accreditation). They were asked if they used the term ‘‘unascertained’’ when they
found no adequate cause for death. Eleven always used the term, 19 used it frequently, 26
occasionally, and seven never. Of the 56 pathologists who used the term 38 would use it
whenever death had occurred while the infant was sharing a bed with an adult and 37 when
there were suspicious features in the history or at autopsy. Eight pathologists admitted using
the term to obtain an inquest.
Sixty-two respondents answered a question about information available to them at the
time of the autopsy and half (32) of these complained that the information was usually
inadequate; they wanted more information about the medical and social history and the
antecedents and circumstances of death. Fifty-two routinely received a report from the
coroner’s officer but only ten regularly had a report from a health professional. Thirty-two
said they sometimes visited the scene of the death. Thirty-eight pathologists believed that
the term SIDS was still useful, 24 did not, and one was undecided. For sudden unexplained
death while sharing a bed with an adult 38 would use the term unascertained, 25 would call
it SIDS, six SUDI, and one asphyxia (some would use different terms in different
circumstances). Eighteen of the 63 pathologists performed fewer than six SUDI autopsies a
year.
There is variation in the use of the term ‘‘unascertained’’ but whereas SIDS implies a
natural cause, unascertained does not exclude unnatural death. The authors of this paper
point out that use of the term ‘‘unascertained’’ could therefore stigmatise the family. They
call for all SUDI to be given the same designation initially and for more specific, or
potentially accusatory, terms to be used only after full investigation, often including an
inquest.
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